Freemont Management’s Merck MRK Stock Holding History

Freemont Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,100	Closed	-$806K	–	103
2024 Q4	$806K	Hold	8,100	–	–	0.35%	72
2024 Q3	$920K	Hold	8,100	–	–	0.45%	65
2024 Q2	$1M	Sell	8,100 -39,600	-83%	-$5.1M	0.47%	50
2024 Q1	$6.29M	Sell	47,700 -14,700	-24%	-$1.81M	0.9%	39
2023 Q4	$6.8M	Hold	62,400	–	–	0.86%	38
2023 Q3	$6.42M	Sell	62,400 -10,400	-14%	-$1.12M	0.96%	36
2023 Q2	$8.4M	Hold	72,800	–	–	1.02%	35
2023 Q1	$7.75M	Hold	72,800	–	–	1.09%	33
2022 Q4	$8.08M	Hold	72,800	–	–	1.27%	26
2022 Q3	$6.27M	Sell	72,800 -1,800	-2%	-$161K	1.14%	30
2022 Q2	$6.8M	Sell	74,600 -3,800	-5%	-$337K	1.18%	30
2022 Q1	$6.43M	Buy	+78,400	New	+$6.18M	0.97%	45
2021 Q4	–	Sell	-113,200	Closed	-$8.5M	–	99
2021 Q3	$8.5M	Buy	113,200 +400	+0.4%	+$30.4K	1.12%	34
2021 Q2	$8.77M	Sell	112,800 -5,414	-5%	-$403K	1.26%	30
2021 Q1	$8.7M	Hold	118,214	–	–	1.42%	31
2020 Q4	$9.23M	Buy	+118,214	New	+$9.04M	1.72%	24

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Freemont Management's MRK Position: Q1 2025 in Review

Freemont Management sold out of Merck (MRK) in Q1 2025, closing a stake of 8,100 shares — an estimated $806K sold.

Freemont Management first reported a position in MRK in Q4 2020 and held it in 16 quarters. The position peaked at $9.23M in Q4 2020. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

Freemont Management reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
Freemont Management sold 8,100 Merck shares in Q1 2025, an estimated $806K.
Freemont Management first reported a position in Merck in Q4 2020 and held it in 16 quarters.
Freemont Management's Merck position peaked at $9.23M in Q4 2020.
3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Freemont Management's 13F filing for Q1 2025, filed 7 May 2025.